A lthough TNF (tumor necrosis factor)-α is best known for its proinflammatory actions, this cytokine also exhibits immunomodulatory effects and regulates diverse functions in kidney, lung, and colon where active Na + transport is important for fluid clearance. [1] [2] [3] [4] Indeed, clinical use of anti-TNF drugs has exposed fundamental effects of this cytokine that preclude their use in congestive heart failure and systemic lupus erythematosus. 1, [5] [6] [7] Micropuncture and whole animal studies first identified cytokines as regulators of renal function, however, the molecular mechanisms that underlie these effects remain unclear. [8] [9] [10] [11] [12] Moreover, although TNF is produced by proximal tubule, medullary thick ascending limb of Henle loop (mTAL), collecting duct, podocytes and mesangial cells, the intrinsic effects of endogenous TNF formed within the kidney are understudied.
A lthough TNF (tumor necrosis factor)-α is best known for its proinflammatory actions, this cytokine also exhibits immunomodulatory effects and regulates diverse functions in kidney, lung, and colon where active Na + transport is important for fluid clearance. [1] [2] [3] [4] Indeed, clinical use of anti-TNF drugs has exposed fundamental effects of this cytokine that preclude their use in congestive heart failure and systemic lupus erythematosus. 1, [5] [6] [7] Micropuncture and whole animal studies first identified cytokines as regulators of renal function, however, the molecular mechanisms that underlie these effects remain unclear. [8] [9] [10] [11] [12] Moreover, although TNF is produced by proximal tubule, medullary thick ascending limb of Henle loop (mTAL), collecting duct, podocytes and mesangial cells, the intrinsic effects of endogenous TNF formed within the kidney are understudied. [13] [14] [15] [16] [17] The TAL plays an important role in the maintenance of blood pressure and has been linked to the development of salt-sensitive hypertension. 18, 19 We previously showed that the TAL produces TNF, and global deletion of this cytokine selectively increases expression of the NKCC2 (Na + -K + -2Cl − cotransporter) isoform A along the TAL. 14, 20 Moreover, TNF produced by cultured mTAL cells acts in an autocrine manner to inhibit in vitro correlates of Na + reabsorption and exogenous administration of recombinant TNF to mice elicits a natriuretic response. 2, 21, 22 We also showed that addition of 1% NaCl to the drinking water induces NFAT-5-dependent TNF production by the mTAL, and increases the levels of this cytokine in urine but not plasma. 23, 24 Importantly, production of TNF by the kidney in response to increased NaCl intake was not associated with an increase in blood pressure and was observed in the absence of an inflammatory response. These data are consistent with the notion that elevated renal levels of TNF are not always detrimental. 25 TNF has important prohypertensive effects in experimental models of hypertension associated with inflammation and involving recruitment of T cells and macrophages, which contribute to end-organ damage in the kidney, however, TNF per se does not increase blood pressure when administered to normal rats, mice, or humans. [26] [27] [28] [29] [30] [31] [32] [33] [34] Moreover, randomized clinical trials have shown that anti-TNF therapy is associated Abstract-We tested the hypothesis that TNF (tumor necrosis factor)-α produced within the kidney and acting on the renal tubular system is part of a regulatory mechanism that attenuates increases in blood pressure in response to high salt intake. Intrarenal administration of a lentivirus construct, which specifically silenced TNF in the kidney, did not affect baseline blood pressure. However, blood pressure increased significantly 1 day after mice with intrarenal silencing of TNF ingested 1% NaCl in the drinking water. The increase in blood pressure, which was continuously observed for 11 days, promptly returned to baseline levels when mice were switched from 1% NaCl to tap water. Silencing of renal TNF also increased NKCC2 (Na
− cotransporter) phosphorylation and induced a selective increase in NKCC2A (NKCC2 isoform A) mRNA accumulation in both the cortical and medullary thick ascending limb of Henle loop that was neither associated with a compensatory decrease of NKCC2F in the medulla nor NKCC2B in the cortex. The NaClmediated increases in blood pressure were completely absent when NKCC2A, using a lentivirus construct that did not alter expression of NKCC2F or NKCC2B, and TNF were concomitantly silenced in the kidney. Moreover, the decrease in urine volume and NaCl excretion induced by renal TNF silencing was abolished when NKCC2A was concurrently silenced, suggesting that this isoform contributes to the transition from a salt-resistant to salt-sensitive phenotype. Collectively, the data are the first to demonstrate a role for TNF produced by the kidney in the modulation of sodium homeostasis and blood pressure regulation. with hypertension in patients with rheumatoid arthritis, suggesting that more precise mechanistic studies are needed to understand the effects of TNF on blood pressure regulation. 35 Recent elegant studies suggest that in vivo effects of TNF are dictated by the cellular sources that produce this cytokine. 36, 37 The present study defines the intrinsic effects of endogenous TNF, produced in the kidney under normotensive and noninflammatory conditions and demonstrates that TNF is part of an adaptive pathway that limits NKCC2A (NKCC2 isoform A) activity and attenuates increases in blood pressure in response to high NaCl intake.
Methods
The data that support the findings of this study are available from the corresponding author on reasonable request.
Mice
Male C57BL/6J mice were maintained on a diet containing 0.4% NaCl and tap water or 1% NaCl in the drinking water ad libitum. All protocols were approved by the New York Medical College Institutional Animal Care and Use Committee and conducted in accordance with National Institutes of Health Guide for the Care and Use of Laboratory Animals.
Preparation and In Vivo Administration of Lentivirus Targeting Vectors
Constructs were generated using standard cloning procedures as previously described 24, 38, 39 ; Methods in the online-only Data Supplement.
Preparation of Renal Tissues and mTAL Cells
Isolation of renal tissues was performed as previously described 24, 38, 39 ; Methods in the online-only Data Supplement.
Blood Pressure Measurements
Blood pressure was determined by tail-cuff plethysmography and radiotelemetry; Methods in the online-only Data Supplement.
Quantitative RT-PCR Analysis
Isolation of total RNA, amplification of cDNA fragments, and quantitative RT-PCR analysis were performed as previously described 24, 38, 39 ; Methods in the online-only Data Supplement.
Western Blot Analysis
Analysis of total and phospho-NKCC2 (pNKCC2) expression was performed as previously described 20 ; Methods in the online-only Data Supplement.
TNF ELISA
Determination of TNF levels in plasma and urine was performed as previously described 40 ; Methods in the online-only Data Supplement.
Metabolic Cage Experiments
Mice placed in metabolic cages were used for studies to evaluate the effects of renal TNF silencing on sodium and chloride excretion; Methods in the online-only Data Supplement.
Statistical Analysis
Data are expressed as mean±SE; GraphPad Prism 4 was used to analyze data sets. One-way ANOVA (followed by Tukey or Dunnett post hoc test) was used for comparisons among groups, and an unpaired Student t test was used to compare data between 2 groups, with the aid of Sigma Plot software. Radiotelemetry data were analyzed by repeated-measures ANOVA. A P value of <0.05 was considered statistically significant.
Results

Validation of Intrarenal Lentivirus Silencing of TNF
A lentivirus strategy was developed to silence TNF production in the kidney by constructing an shRNA that targeted exon 4 of the TNF gene (U6-TNF-ex4; Figure 1A ). The ability of this construct to reduce TNF mRNA levels was verified in primary cultures of mouse mTAL cells in which both basal and stimulated (NaCl; 400 mOsmol/kg·H 2 O) levels of TNF mRNA were inhibited ( Figure 1B ). For in vivo silencing of TNF, purified U6-TNF-ex4 or control lentivirus (U6) was injected directly into each kidney as described. 24, 39 Three days later qRT-PCR analysis showed that TNF mRNA was markedly reduced in kidney but not spleen or liver, major extrarenal sites of TNF expression ( Figure 1C through 1E ). Intrarenal injection of lentivirus did not produce renal damage as previously described. 39 Collectively, the data show that the U6-TNF-ex4 construct silences TNF in the kidney and does not escape into the circulation to inhibit TNF production at other sites.
Effects of Renal-Specific TNF Silencing on Blood
Pressure, NKCC2A mRNA Accumulation, and NKCC2 Phosphorylation
Mice were provided 1% NaCl in the drinking water to study the intrinsic effects of TNF produced within the kidney on blood pressure regulation under normal and high salt conditions. This approach circumvented the prohypertensive effects of TNF observed in models of Ang (angiotensin) II-induced hypertension 26, 30, 31, 33 and increases TNF levels in urine but not plasma, signifying renal rather than systemic TNF production. 24 Baseline systolic blood pressure was similar in mice ingesting tap water and a normal salt diet that were given U6 or U6-TNF-ex4 ( Figure 2A ). However, silencing TNF increased systolic blood pressure when mice were switched to 1% NaCl for 3 days compared with mice injected with U6 control ( Figure 2A ). As global deletion of TNF increases NKCC2A mRNA accumulation, 20 we determined if this effect was dependent on TNF produced within the kidney. Indeed, a selective increase in outer medullary NKCC2A mRNA levels was observed in mice injected with U6-TNF-ex4 and given 1% NaCl ( Figure 2B and 2C) . Isoform-specific antibodies are not available, and while total NKCC2 expression did not change an increase in pNKCC2 expression was observed in mice in which TNF was silenced ( Figure 2D and 2E) . Collectively, the data indicate that the selective increase in NKCC2A mRNA abundance and pNKCC2 levels, in response to high salt intake in the absence of renal TNF, occurs concomitantly with an increase in systolic blood pressure.
Renal Silencing of TNF/Characteristics of NaClInduced Increases in Blood Pressure
Injection of control or TNF silencing lentivirus had no effect on baseline blood pressure in mice ingesting a standard diet and tap water from day −2 to day 0 ( Figure 3A) . However, an increase in blood pressure was observed 1 day after mice began drinking 1% NaCl, an effect that was sustained for 5 days ( Figure 3A ). Additional studies showed that blood pressure remained elevated for 11 days while mice were drinking 1% NaCl and that blood pressure rapidly returned to baseline when mice were switched to tap water (days 12-16; P<0.05), and increased and remained elevated when they were switched back to 1% NaCl (days 17-21; P<0.05; Figure 3B ). A parallel study using radiotelemetry was performed to acquire data >3 consecutive weeks during which time mice were subjected to a sequence of normal, high, and normal NaCl intake periods ( Figure 3C ). The rapid, sustained, and reversible increase in MAP detected by radiotelemetry supports the concept that TNF produced in the kidney is part of an adaptive mechanism that attenuates increases in blood pressure in normotensive mice ingesting high NaCl. Indeed, urinary levels of TNF were diminished in mice treated with intrarenal U6-TNF-ex4 while plasma levels of TNF remained unchanged ( Figure 3D and 3E). Overall, these data indicate that in mice ingesting 1% NaCl, silencing TNF in the kidney results in elevated blood pressure responses that are rapid, reversible, and sustained until mice are once again given tap water to drink.
Silencing NKCC2A Reverses the Increase in Blood Pressure in shTNF Mice
The extent to which the increase in NKCC2A contributed to the salt-induced increase in MAP following silencing of renal TNF was determined by concomitantly silencing NKCC2A in the kidney. We previously designed constructs that specifically silence NKCC2 isoforms. 38 Accordingly, MAP was determined in mice that received intrarenal injections of either TNF silencing lentivirus (U6-TNF-ex4) alone, or a mixture of U6-TNF-ex4 and U6-N2A-ex4 to silence NKCC2A. MAP was similar in both groups of mice that ingested tap water for 3 days ( Figure 4A ). However, the high salt-induced increase in MAP observed in mice injected with U6-TNF-ex4 was completely absent in mice when NKCC2A was silenced ( Figure 4A) . Similarly, MAP, averaged >7 days of high NaCl intake, was lower in mice that received both U6-TNF-ex4 and U6-N2A-ex4 compared with mice in which only TNF was silenced ( Figure 4B ). These data indicate that the elevated expression of NKCC2A, in mice lacking TNF in the kidney, contributes to the increase in MAP in mice ingesting high NaCl.
Effects of Renal TNF Silencing on NKCC2 Isoform Expression
Because silencing NKCC2A abolished the NaCl-dependent increase in blood pressure observed in the absence of renal TNF, we determined the effects of silencing TNF and NKCC2A concomitantly in the kidney on NKCC2 isoform expression. In these experiments, tissue was obtained after mice were injected with empty lentivirus (U6), U6-TNF-ex4, or a mixture of U6-TNF-ex4 and U6-N2A-ex4 for 3 days then given 1% NaCl for an additional 1 day. The data show that NKCC2A mRNA expression was significantly increased in both medulla and cortex from mice with TNF silencing compared with the control group (U6) in response to high NaCl ( Figure 5A and 5C ). In contrast, neither knockdown of TNF nor NKCC2A affected NKCC2F or NKCC2B mRNA levels ( Figure 5B and 5D) . The data also confirm that injection of U6-N2A-ex4 specifically decreases NKCC2A mRNA abundance in renal cortex and medulla. 
Effects of Renal TNF and NKCC2A Silencing on Electrolyte Excretion
The contributions of NKCC2A and TNF to electrolyte and urine excretion were determined using mice that were placed in metabolic cages and received intrarenal injections of control (U6), U6-TNF-ex4, or a mixture of U6-TNF-ex4 and U6-N2A-ex4. Three days after silencing, mice were switched from tap water to 1% NaCl in the drinking water, and urine was collected for 24 hours. Renal silencing of TNF elicited a decrease in urine volume, sodium, and chloride excretion ( Figure 6A through 6C) . Concomitant inhibition of TNF and NKCC2A reversed the inhibitory effects of TNF silencing on urine volume, sodium, and chloride excretion. Taken together, these data suggest that renal TNF silencing sets in motion changes in NKCC2A expression and NKCC2 activity that attenuate the diuretic and natriuretic response to NaCl.
Discussion
This study provides evidence of a paradigm shift about the role of TNF in hypertension and shows that TNF, produced within the kidney and acting within the tubular compartment in normotensive mice, is part of an adaptive mechanism that regulates blood pressure in response to increases in sodium intake via a mechanism involving regulation of the NKCC2A isoform along the cortical and medullary TAL. We demonstrated that 1% NaCl in the drinking water, which increases urinary but not plasma levels of TNF, increased blood pressure in mice in which renal TNF expression was silenced, but had no effect when ingested by mice injected with control lentivirus. The increase in blood pressure was observed 1 day after 1% NaCl was provided, remained elevated until mice were subsequently given tap water, and was accompanied by a selective increase in NKCC2A isoform and pNKCC2 expression. Concomitant silencing of NKCC2A and TNF in the kidney not only prevented the increase in blood pressure but also reversed the decrease in urine volume as well as the urinary excretion of Na + and Cl − induced by renal silencing of TNF. Previously, we showed that global genetic deletion of TNF in mice on a normal salt diet selectively increases NKCC2A isoform expression, NKCC2 activity, and ambient urine osmolality. 20 Although those findings suggested that TNF was an endogenous regulator of NKCC2, consistent with previous work in rats, 41 expression of TNF by many cell types throughout the body prevented exclusion of nonrenal and developmental effects of this cytokine on the kidney. For the present study, we designed lentivirus constructs suitable for intrarenal administration in adult mice that silence key components hypothesized to regulate a TNF-dependent regulatory axis important for the adaptive response to increases in NaCl intake. We demonstrated that renal silencing of TNF did not change baseline blood pressure in mice ingesting a normal salt diet. However, rapid, sustained, and reversible increases in Figure 2 . Effects of TNF (tumor necrosis factor) silencing on blood pressure and NKCC2 (Na + -K + -2Cl − cotransporter) isoforms. A, Mice were pretreated with control (U6) or TNF silencing (U6-TNF-ex4) lentivirus for 4 d and were then given either tap water or 1% NaCl for 3 d. Systolic blood pressure (SBP) was measured daily by tail-cuff plethysmography (n=4). B and C, Total RNA was isolated from the outer medulla, and qRT-PCR was performed to determine the effects of TNF silencing on NKCC2A (NKCC2 isoform A) and NKCC2F (n=4). D and E, Analysis of total and phospho-NKCC2 expression by Western blot (n=6).
blood pressure were observed when mice that received intrarenal injections of TNF silencing lentivirus ingested 1% NaCl in the drinking water. Moreover, concurrent decreases in sodium excretion were observed as NKCC2A, and pNKCC2 expression increased in the context of TNF silencing and an increase in NaCl intake. Importantly, both the increase in blood pressure and a decrease in sodium excretion were prevented by concomitant silencing of TNF and NKCC2A in the kidney. Pressure natriuresis involves inhibition of sodium transporters in several nephron segments including the TAL, which reabsorbs ≈25% of filtered NaCl. Our earlier studies using primary cultures of mTAL cells showed that TNF inhibited in vitro correlates of natriuresis in a COX-2-dependent manner. 2, 21, 42 Importantly, these findings were supported and extended by the first in vivo demonstration that TNF affects renal hemodynamics and excretory function in mice. 22 In those studies, acute administration of TNF to anesthetized mice increased urine flow, sodium excretion, and fractional sodium excretion while decreasing renal blood flow and glomerular filtration rate. The present study in conscious mice is the first fully integrated analysis linking endogenous TNF produced within the kidney to the attenuation of salt-induced increases in blood pressure by a mechanism involving NKCC2A.
The reabsorption of NaCl along the TAL occurs mainly via NKCC2 expressed exclusively in the apical membrane of the TAL and macula densa. 43, 44 Mutations of the NKCC2 Figure 3 . Features of blood pressure changes induced by renal silencing of TNF (tumor necrosis factor). A, Baseline blood pressure was established in mice injected with U6 or U6-TNF-ex4. Mice were then switched from tap water to 1% NaCl in the drinking water for 5 d (n=4; *P<0.05). B, Summation of blood pressure values from mice that ingested a sequence of 1% NaCl, tap water, and 1% NaCl for the indicated days (n=4); P<0.05 is for comparison of 1% NaCl vs tap water in U6-TNF-ex4-treated mice. C, Daily averages of blood pressure assessed by radiotelemetry in mice injected with U6 or U6-TNF-ex4 and given either tap water or 1% NaCl (n=6); D and E, TNF levels in urine and plasma were determined in mice given 1% NaCl for 3 d after treatment with control or silencing vectors (n=6). − cotransporter isoform A) prevents NaCl-induced increases in mean arterial pressure (MAP) induced by knockdown of TNF (tumor necrosis factor) in the kidney. A, Mice were implanted with radiotelemetry probes and injected with either U6-TNF-ex4 or a combination of U6-TNF-ex4 and U6-N2A-ex4 to concomitantly silence NKCC2A. MAP was determined in mice given tap water and then 1% NaCl (n=6). B, Summation of MAP for mice given 1% NaCl.
gene (SLC12A1) demonstrated to cause reduced NKCC2 activity, and detected by screening >3000 members of the Framingham Heart Study, were associated with a significant reduction in blood pressure and risk of death because of cardiovascular disease. 45, 46 Although a single gene encodes for NKCC2, differential splicing of NKCC2 pre-mRNA results in formation of 3 major isoforms, NKCC2A, NKCC2B, and NKCC2F arising from variable exon 4. 47, 48 Prominent differences between the isoforms include their relative affinities for chloride; namely, high affinity NKCC2B and NKCC2A versus low affinity NKCC2F, and the designation of NKCC2A as a high capacity transporter whose expression is induced by high NaCl concentration in mTAL cells. 38, 49 As renal-derived TNF is an inhibitor of NKCC2A mRNA accumulation it is important to note that the functional changes we observed in this, and a previous, 20 study could have been foretold by the elegant studies performed using NKCC2A knockout mice. 50 Particularly, relevant are the findings that NKCC2A may be important for preventing salt loss under conditions of elevated rates of NaCl delivery to the TAL as they are consistent with the relatively high transport capacity of NKCC2A and the observation that the regulatory effects of this isoform were seen only after intraluminal flow was increased in the context of saline loading. 50 It is interesting to note that while genetic deletion of TNF was associated with an increase in NKCC2A and ambient urine osmolality, NKCC2A knockout mice exhibited a decrease in osmolality. 20, 50 It also is intriguing to speculate how the contribution of NKCC2A to TGF responses when tubular NaCl concentration is high may relate to the decreasing renal blood flow and glomerular filtration rate in response to TNF. 22, 50 Although the mechanism by which TNF selectively influences NKCC2A remains to be determined, changes in salt intake can influence the expression of NKCC2 isoforms, 51 and differential splicing of NKCC2 pre-mRNA and NKCC2 protein phosphorylation − cotransporter) isoforms. qRT-PCR was performed for NKCC2A (NKCC2 isoform A) and NKCC2F on total RNA obtained from medulla (A and B) , and NKCC2A and NKCC2B in cortex (C and D) of mice that were injected with U6, U6-TNF-ex4, or a combination of U6-TNF-ex4 and U6-N2A-ex4 and given 1% NaCl for 7 d (n=6). − cotransporter isoform A) on renal excretory function. Mice were injected with U6, U6-TNF-ex4, or a combination of U6-TNF-ex4 and U6-N2A-ex4 and were acclimatized for 3 d in metabolic cages and given tap water ad libitum. Urine was collected for determinations of (A) volume, (B) sodium, and (C) chloride 24 h after ingestion of 1% NaCl (n=6).
are important pathways for the regulation of NKCC2 that may be under tonic suppression by TNF.
Hypertension is a major independent risk factor for heart attack, stroke, and end-stage renal disease 52 and increased NaCl reabsorption by the TAL contributes to salt-sensitive hypertension. 18, 19, 53 Although a link between dietary salt intake and hypertension is well established, elevations in blood pressure subsequent to an increase in salt intake occur in some individuals but not others. 54 Mechanisms that underlie the development of salt-dependent hypertension are not completely understood. Indeed, multiple reasons likely account for alterations of renal salt and water handling that may predispose individuals to changes in blood pressure in response to salt intake. The TAL has been implicated in genetic and race factors that increase sodium reabsorption, and variations in Na + reabsorption in this segment have been linked to hypertension in both animal models and humans. [55] [56] [57] Collectively, these studies are consistent with the concept that elevated NKCC2 activity along the TAL may contribute to increases in blood pressure related to dietary NaCl intake. 58, 59 A variety of molecules acting via autocrine and paracrine mechanisms regulate transport function in the TAL, and additional regulatory pathways remain to be discovered. 60 Thus, it is critically important to understand the local endogenous actions of cytokines such as TNF along the nephron.
In several experimental models of hypertension associated with renal injury, inflammation and immune system activation, genetic deletion of TNF or administration of etanercept decreases blood pressure. Baseline blood pressure was not altered by either genetic deletion or pharmacological inhibition of TNF, similar to our studies, however, the hypertensive effects of salt intake were observed in the context of Ang II infusion. 30, 31, 33 Accordingly, the increase in blood pressure after intrarenal silencing of TNF in the present study are not in conflict with these previous findings but rather illustrate an intrinsic effect of this cytokine in the context of a normotensive and noninflammatory setting in which the renin-angiotensin system was not activated. This paradigm shift regarding a renal regulatory function of TNF via a selective inhibitory effect on NKCC2A indicates that this cytokine functions as part of an axis that attenuates increases in blood pressure in response to increases in salt intake. Interestingly, hypertension has consistently been observed as a side effect in randomized clinical trials of anti-TNF therapy being administered for rheumatoid arthritis. 35 However, as the present study is the first to determine the mechanistic relationship between TNF production in the kidney, NKCC2 activity, and blood pressure regulation in response to increases in sodium intake, and the previous clinical trials could not have been designed to address this relationship, further studies will be needed to extrapolate the current findings in mice to salt-dependent increases in blood pressure in humans.
Perspectives
This study is the first to demonstrate that endogenous TNF produced within the kidney is part of a heretofore unrecognized intratubular cytokine-based mechanism that regulates blood pressure responses to salt intake via specific inhibition of NKCC2A, the NKCC2 isoform with transport and binding characteristics best suited to respond to increases in tubular fluid salt concentration and flow. The data support a paradigm shift from the concept that TNF only exerts detrimental effects in the kidney, and are relevant not only to novel mechanisms that regulate blood pressure and electrolyte excretion but also toward an appreciation of the elevated blood pressure reported in randomized clinical trials designed to test the efficacy of anti-TNF reagents in patients with rheumatoid arthritis.
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